Glaxo Plans Five Vaccines Over Five Years

[Guest guest]

" Zeus " <info

Glaxo Plans Five Vaccines Over Five Years

Thu, 14 Jul 2005 11:50:19 +0100

 

 

 

" Ingri Cassel " vaclib

Re: Glaxo Plans Five Vaccines Over Five Years

Mon, 11 Jul 2005 12:49:35 -0700

 

 

In ALL five of these vaccines they are using MPL, the latest

squalene-based

adjuvant produced by Corixa, a subsidary of GlaxoSmithKline. Do a

search on MPL adjuvant for verification of this. And encourage

everyone to get Gary

Matsumoto's book, Vaccine A www.Vaccine-A.com

 

Although Gary's information is incredible and reads like an investigative

novel, he has smallpox vaccine propaganda in his book -- citations from

books printed in 1981 and 1984, when they were rewriting a lot of history.

 

~Ingri

 

 

 

http://www.latimes.com/business/la-fi-glaxo1jul01,1,4146031.story?coll=la-he

Glaxo Plans Five Vaccines Over Five Years

 

The company will target markets that could reach $18 billion by 2010

and will double its flu shot production to supply the U.S.

 

From Reuters

 

GlaxoSmithKline aims to launch five major vaccines over the next five

years targeting markets that could reach $18 billion by 2010, Europe's

biggest drug maker said Thursday.

 

The company also plans to double manufacturing capacity in Dresden,

Germany, for its flu shot Fluarix to 80 million doses a year by 2008 in

order to supply the U.S. market.

 

Vaccines have long been viewed as a low-growth, low-price business, but

Glaxo says this is changing with the arrival of new technologies. Some

of its new vaccines will become pharmaceutical blockbusters with sales

above $1 billion a year, the company says.

 

" The global vaccines market is now poised for accelerated growth, " David

Stout, Glaxo president of pharmaceutical operations, told reporters

during a vaccines seminar in London.

 

Most attention is focused on Cervarix, Glaxo's big new hope for

preventing cervical cancer.

 

It will compete with Merck & Co.'s experimental product Gardasil,

which is further along in the process of getting to market.

 

Cervarix has been touted by industry analysts as a potential

$4-billion-a-year seller. Many analysts now expect Glaxo to seek

approval from the Food and Drug Administration in 2007, although it

might be able to apply in 2006 if clinical trials progress rapidly.

 

Like Gardasil, the vaccine targets a sexually transmitted infection

called human papillomavirus, which causes cervical cancer, the

second-biggest cancer killer in women.

 

Although Cervarix alone has the potential to transform Glaxo's vaccine

business, the company also has high hopes for four other major new

vaccines that are scheduled for launch by 2010.

 

They include Rotarix, for preventing a common cause of severe diarrhea

in children called rotavirus.

 

Glaxo also is pursuing a vaccine for pneumococcal disease known as

Streptorix as well as new vaccine combinations against meningitis and

an improved flu vaccine.

_____________________________

 

30 Jun 2005

 

Glaxo SmithKline had a " Vaccine Day " today. It was a dog and pony

show to educate their partners about their vaccine business and the

very significant role that vaccines will play in the future of their

company (their words). Here are some of their projections going out

to 2010.

 

total vaccine market - $18 Billion per year (yes billion with a B)

 

strep vaccine market - $3.2 Billion per year

 

meningitis vaccine market - $1.5 Billion per year

 

If anyone doubts that vaccines are BIG BIG business and it's the

dollars that drive decisions, rather than the health of the users,

take another look at those numbers.

 

Thimerosal and other preservatives aside, the havoc that the ever

expanding vaccine schedule (and the drug companies will expand it to

infinity if allowed to) wreaks on an immune system that evolved just

fine on it's own for millions of years cannot be imagined and is

probably far worse than even the most pessimistic of us could ever

imagine.

 

forwarded by

Zeus Information Service

Alternative Views on Health

www.zeusinfoservice.com